Rhenman & Partners Asset Management Ab

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$810.5M
Q ending 2026-03-31
Prior quarter
$1.07B
Q ending 2025-12-31
Change
-24.3% QoQ · -6.8% YoY
Positions
86
reported holdings

Largest positions

All 86 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Boston Scientific CorpBSXShares$39.2M625K
Regeneron PharmaceuticalsREGNShares$37.2M48K
Lilly Eli & CoLLYShares$31.0M34K
Insmed IncINSMShares$26.1M160K
Cvs Health CorpCVSShares$24.2M337K
Gilead Sciences IncGILDShares$23.4M168K
Thermo Fisher Scientific IncTMOShares$20.3M41K
Biogen IncBIIBShares$20.0M109K
Vertex Pharmaceuticals IncVRTXShares$19.4M43K
Alignment Healthcare IncALHCShares$18.6M1.1M
Intuitive Surgical IncISRGShares$17.0M37K
Cencora IncCORShares$16.5M52K
Stryker CorporationSYKShares$15.7M48K
Abbvie IncABBVShares$15.6M72K
Veeva Sys IncVEEVShares$15.0M85K
Mckesson CorpMCKShares$14.6M17K
Jazz Pharmaceuticals PlcShares$14.3M76K
Guardant Health IncGHShares$13.4M145K
Neurocrine Biosciences IncNBIXShares$13.3M101K
Edwards Lifesciences CorpEWShares$13.1M163K
Madrigal Pharmaceuticals IncMDGLShares$12.6M24K
United Health Group IncUNHShares$12.3M46K
Procept Biorobotics CorpPRCTShares$11.9M475K
Biomarin Pharmaceutical IncBMRNShares$11.7M207K
Abbott LaboratoriesABTShares$11.5M112K
Alnylam Pharmaceuticals IncALNYShares$11.4M34K
Royalty Pharma PlcShares$11.2M233K
Axsome Therapeutics IncAXSMShares$10.8M64K
Natera IncNTRAShares$10.3M52K
Tenet Healthcare CorpTHCShares$10.2M54K
Adaptive Biotechnologies CorADPTShares$10.0M720K
Livanova PlcShares$9.9M155K
Elevance Health IncELVShares$9.5M32K
Arrowhead Pharmaceuticals InARWRShares$9.1M145K
Glaukos CorpGKOSShares$9.0M84K
Iqvia Hldgs IncIQVShares$9.0M53K
Syndax Pharmaceuticals IncSNDXShares$8.9M379K
Mirum Pharmaceuticals IncMIRMShares$8.6M93K
Ideaya Biosciences IncIDYAShares$8.5M256K
Pennant Group IncPNTGShares$8.4M275K
Nuvalent Inc5AXShares$8.3M81K
Waystar Hldg CorpWAYShares$8.3M343K
Anteris Technologies GlobalAVRShares$8.0M1.4M
Medtronic PlcShares$7.8M90K
Oscar Health IncOSCRShares$7.6M660K
Iovance Biotherapeutics IncIOVAShares$7.2M2.1M
Mineralys Therapeutics IncMLYSShares$7.1M263K
Ionis Pharmaceuticals IncIONSShares$7.0M93K
Dianthus Therapeutics IncDNTHShares$6.9M82K
Bridgebio Pharma IncBBIOShares$6.7M91K
Apogee Therapeutics IncAPGEShares$6.3M75K
Structure Therapeutics IncGPCRShares$6.2M128K
Cardinal Health IncCAHShares$5.7M27K
Encompass Health CorpEHCShares$5.4M56K
Amgen IncAMGNShares$5.3M15K
Viking Therapeutics IncVKTXShares$5.2M160K
Nurix Therapeutics IncNRIXShares$4.9M314K
Alkermes PlcShares$4.7M133K
Charles Riv Labs Intl IncCRLShares$4.5M26K
Moonlake ImmunotherapeuticsMLTXShares$4.5M240K
Krystal Biotech IncKRYSShares$4.3M17K
Doximity IncDOCSShares$4.3M184K
Nektar TherapeuticsNKTRShares$4.2M59K
Denali Therapeutics IncDNLIShares$3.8M199K
Stevanato Group S P AShares$3.8M275K
Relay Therapeutics IncRLAYShares$3.6M360K
Cooper Cos IncCOOShares$3.6M50K
Sionna Therapeutics IncSIONShares$3.5M88K
Ascendis Pharma A/SShares$3.4M15K
Danaher CorporationDHRShares$3.4M18K
Insulet CorpPODDShares$2.9M14K
Agilent Technologies IncAShares$2.8M25K
Stoke Therapeutics IncSTOKShares$2.7M83K
Esperion Therapeutics Inc NeShares$2.7M985K
Immunocore Hldgs PlcIMCRShares$2.6M86K
Ocular Therapeutix IncOCULShares$2.6M305K
Steris PlcShares$2.5M12K
Vericel CorpVCELShares$2.3M70K
Kura Oncology InKURAShares$2.2M272K
The Cigna GroupCIShares$2.1M8K
Brightspring Health Svcs IncBTSGShares$2.1M50K
Xenon Pharmaceuticals IncXENEShares$1.6M28K
Align Technology IncALGNShares$1.3M8K
Novocure LtdShares$763K70K
Alphatec Hldgs IncATECShares$762K70K
Compass Therapeutics IncCMPXShares$609K115K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.